Peter MacCallum Cancer Centre and Cartherics to work on CAR-T cell therapy for ovarian cancer
Peter MacCallum Cancer Centre (Peter Mac) in Australia and Cartherics Pty Ltd have entered into…
February 28, 2023 - 4 minutes
Australia
Get the latest biotech Australia news. Learn more about the latest regulations, collaboration deals, and technology advancements of biotech companies in Australia.
Certa scleroderma study shows improvement in more than 60% of patients
Certa Therapeutics has announced what it says are ground-breaking clinical trial data for FT011, its…
February 7, 2023 - 5 minutes
Computational chemistry and cancer
by Martin Slater, Cresset Discovery Computational chemistry offers a fast and innovative approach to drug…
February 1, 2023 - 3 minutes
Cartherics granted first patent in China
Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of cancer,…
January 9, 2023 - 2 minutes
Pictor receives $5M in funding for Covid antibody test and human and animal portfolios
Pictor, a global leader in immunodiagnostics, has announced a $5 million funding round to help…
December 6, 2022 - 3 minutes
LAG-3: The next big checkpoint inhibitor target
Since their first approval a decade ago, immune checkpoint inhibitors have been gaining momentum in…
November 29, 2022 - 7 minutes
BIA and Exopharm sign joint research agreement to develop integrated technology
Slovenian-based Sartorius BIA Separations (BIA), a bio-chromatography company, and Australia's Exopharm Ltd., a company working…
November 23, 2022 - 4 minutes
Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma
The Peter MacCallum Cancer Centre (Peter Mac) and Cartherics Pty Ltd (Cartherics) have entered into…
November 8, 2022 - 3 minutes
Telix Pharmaceuticals sees positive results in kidney cancer imaging study
Telix Pharmaceuticals Limited said it has highly positive top-line results from its pivotal phase III…
November 8, 2022 - 3 minutes
The hottest private biotech companies in Australia
Australia has a strong base in biotechnology, with many incentives for R&D and commercialization. Here…
October 18, 2022 - 5 minutes
A-Alpha Bio and Bristol Myers Squibb to collaborate on protein degradation
A-Alpha Bio, a synthetic biology and machine learning company that measures and engineers protein-protein interactions…
October 14, 2022 - 2 minutes
Adalta and GPCR Therapeutics to collaborate on novel cancer treatments
AdAlta Limited and GPCR Therapeutics Inc, are set to collaborate to evaluate AdAlta’s CXCR4 inhibiting…
October 13, 2022 - 4 minutes
